Results 251 to 257 of about 26,612 (257)

Sitagliptin: A Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Annals of Pharmacotherapy, 2006
exaly  

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180

Frontiers in Immunology, 2019
Yosuke Mai, Kentaro Izumi, Wataru Nishie   +2 more
exaly  

Synthesis of a Dipeptidyl Peptidase-4 Inhibitor

Synfacts, 2014
openaire   +1 more source

Genetically Targeted Dipeptidyl Peptidase-4 Inhibitor Use in a Patient with a Novel Mutation of MODY type 4

Clinical Medicine Insights: Endocrinology and Diabetes, 2015
Vijay Shivaswamy, Eric Rush
exaly  

Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes

Expert Opinion on Pharmacotherapy, 2012
exaly  

Dipeptidyl Peptidase 4 Inhibitor–Associated Bullous Pemphigoid

Mayo Clinic Proceedings
Shohei Kitayama, Teruhiko Makino, Tadamichi Shimizu   +2 more
openaire   +2 more sources

Dipeptidyl-Peptidase 4 (DPP4) Inhibitors

openaire   +1 more source